On Tuesday, public health officials approved a second booster shot for everyone over age 50, starting a regulatory process that could be offered at pharmacies this week.
If everyone 12 and older received the mRNA vaccine-like Pfizer or Moderna, or two months after receiving the Johnson & Johnson vaccine, they were already eligible to receive the booster five months after the initial vaccine series.
But for those over 50, the age group identified as vulnerable, OFFICIALS from the FDA and the CENTERS for Disease Control and Prevention decided that data on reduced immunity justified another shot four months after the first booster.
So far, U.S. data on secondary boosters is limited. But data from Israel suggest that additional booster shots can provide temporary protection and reduce the risk of death in adults over 60.